| Cat.No. | Name | Information |
|---|---|---|
| M6189 | Ossirene (AS101) | Ossirene (AS101), a potent in vitro and in vivo immunomodulator, is a novel inhibitor of IL-1beta converting enzyme. |
| M6223 | Tocilizumab | Tocilizumab is a humanized monoclonal antibody that binds to the interleukin-6 receptor, MW: 148 KD. |
| M10139 | Anakinra | Anakinra (Raleukin) is an antagonist of recombinant, nonglycosylated human IL-1R. |
| M41997 | IL-1β-IN-1 | IL-1β-IN-1, cannabidiol derivative, is a potent IL-1β inhibitor. |
| M41996 | Lys-D-Pro-Thr | Lys-D-Pro-Thr, an IL-1beta analogue, is a potent IL-1 inhibitor. |
| M41995 | IL-1β-IN-2 | IL-1β-IN-2, cannabigerol derivative, is a potent IL-1β inhibitor. |
| M41994 | Y13g dihydrochloride | Y13g dihydrochloride is the potent inhibitor of both AChE and IL-6. |
| M41993 | Truncated ADR58 | Truncated ADR58 is obtained by truncating full-length ADR58 from 71 bases to 31 bases. |
| M41992 | Ro26-4550 | Ro26-4550 is a low micromolar antagonist of IL-2/IL-2Rα binding with an IC50 value of 3 μM. |
| M41990 | Semapimod | Semapimod, an inhibitor of proinflammatory cytokine production, can inhibit TNF-α, IL-1β, and IL-6. |
| M41989 | Hedycoronen A | Hedycoronen A has inhibitory activity on the IL-6, IL-12 p40, and TNF-α production in LPS-Stimulated BMDCs, with IC50s of 9.1 μM, 5.6 μM, and 46.0 μM. |
| M40876 | Ebdarokimab | Ebdarokimab is a monoclonal antibody to IL-12p40/IL-23 that can be used in studies related to inflammatory bowel disease (IBD). |
| M40875 | Brazikumab | Brazikumab is a human IgG2 monoclonal antibody targeting IL-23 that selectively binds to the p19 subunit of IL-23 and has a KD value of 0.138 nM against human IL-23 for Crohn's disease (CD). |
| M40708 | DC-806 | DC-806 is an orally active small molecule inhibitor of IL-17 for studies related to psoriasis. |
| M40707 | JNJ-2113 | JNJ-2113 is a novel, orally active IL-23R peptide inhibitor for studies related to plaque psoriasis. |
| M40611 | PF-04236921 | PF-04236921 is a fully human IgG2 monoclonal antibody targeting the interleukin IL-6 for studies related to Crohn's disease and rheumatoid arthritis. |
| M40610 | PF-07275315 | PF-07275315是一种靶向IL-13R，IL-4R和TSLP的三特异性抗体，可用于特应性鼻炎的相关研究。 |
| M40609 | Eblasakimab | Eblasakimab is a potential first-in-class, novel monoclonal antibody that targets the IL-13 receptor alpha 1 subunit (IL-13Rα1) and inhibits signaling of the pro-inflammatory cytokines IL-4 and IL-13. It can be used in studies related to atopic dermatitis (AD). |
| M38978 | Koaburaside | Koaburaside shows antioxidant activity with an IC50 of 9.0 μM for DPPH-free radical scavenging assay. Koaburaside inhibits histamine release and expressions of IL-6 and TNF-α in human mast cells. Koaburaside also effectively inhibits influenza A neuraminidase. |
| M38977 | 1,11b-Dihydro-11b-hydroxymedicarpin | Medicarpin, a natural pterocarpan, heals cortical bone defect by activation of Notch and Wnt canonical signaling pathways. Medicarpin down-regulates pro-inflammatory cytokines like TNF-α, IL-6 and IL-17A, while up-regulates anti-inflammatory cytokine IL-10 in arthritis (CIA) model of mice. |
| M30462 | (S,S)-Formoterol | (S,S)-Formoterol ((+)-Formoterol) is a (S,S)-enantiomer of Formoterol. (S,S)-Formoterol can promote asthma by enhancing IL-4 production in mast cells of the asthmatic airway. |
| M30313 | Kansuinine A | Kansuinine A inhibits IL-6-induced Stat3 activation. Kansuinine A possesses antiviral and anticancer activity. |
| M30255 | Armillarisin A | Armillarisin A has the potential for the ulcerative colitis (UC) study. Armillarisin A increases IL-4 and lower IL-1β. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
